ArticlemedRxiv : the preprint server for health sciences2025
Napsin A-specific T cell clonotypes are associated with improved clinical outcomes in patients receiving checkpoint immunotherapy for metastatic non-small cell lung cancer.
Natalie J Miller et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.